Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · CIK 1606498 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $24.99Day +0.00%Mkt cap $1.2B1Y +114.1%Off 52W high −2.0%Vol (1Y) 77.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,955 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.7% of sh out |
| Days to cover2.4d |
| 13F net flow (QoQ)−4.87% |
| Top-10 13F concentration57.9% |
| Next report (est.)2026-08-04 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$715.9M |
| Earnings (TTM)-$74.4M |
| ROE−9.1% |
| Net margin−10.4% |
| ROIC−5.9% |
| Debt / equity0.13× |
| Sales growth 3Y0.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+122.5% |
| 1Y+114.1% |
| 3Y+2.1% |
| 5Y−34.1% |
| 10Y−26.7% |
| Since incept. (ann.)−4.1% |
Total return through 2026-07-30 · series begins 2014-10-21. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)77.8% |
| Ann. volatility (3Y)54.5% |
| Sharpe (1Y)1.27 |
| Sharpe (3Y)0.24 |
| Max drawdown (1Y)−16.5% |
| Max drawdown (3Y)−59.9% |
| Beta (3Y vs SPY)2.43 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 6.8M | $96M | 14.72% | +1.4% |
| T. Rowe Price Investment Management, Inc. | 5.3M | $75M | 11.46% | −14.3% |
| BROWN ADVISORY INC | 2.2M | $31M | 4.80% | +15.3% |
| DIMENSIONAL FUND ADVISORS LP | 2.1M | $29M | 4.41% | −4.9% |
| ARMISTICE CAPITAL, LLC | 2.0M | $28M | 4.30% | −37.5% |
| STATE STREET CORP | 2.0M | $28M | 4.24% | +0.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $28M | 4.24% | new |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2M | $17M | 2.66% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-05 | $0.11 | −21.4% | $182.2M | +8.8% |
| 2025-12-31 | 2026-02-24 | — | — | $180.9M | +0.7% |
| 2025-09-30 | 2025-11-05 | −$0.03 | −133.3% | $177.8M | +4.3% |
| 2025-06-30 | 2025-08-05 | −$1.66 | −4250.0% | $175.0M | +1.9% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-04 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
US 100%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
